In our cohort, FGF-23 correlated not only with glomerular filtration rate (GFR) but also with cardiac biomarkers such as NT-proBNP and hs-TnT (see Supplementary Figure S3), reflecting the cardiorenal interaction in amyloid cardiomyopathy. This evidence concerns the gene NPPB and cardiac amyloidosis.